BlackRock Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.15M | Sell |
155,257
-40
| -0% | -$553 | ﹤0.01% | 2174 |
|
|
2016
Q3 | $2.81M | Sell |
155,297
-418
| -0.3% | -$7.55K | ﹤0.01% | 1895 |
|
|
2016
Q2 | $2.24M | Buy |
155,715
+8,712
| +6% | +$125K | ﹤0.01% | 2009 |
|
|
2016
Q1 | $1.76M | Buy |
147,003
+901
| +0.6% | +$10.8K | ﹤0.01% | 2087 |
|
|
2015
Q4 | $1.95M | Buy |
146,102
+1,439
| +1% | +$19.2K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $1.55M | Buy |
144,663
+253
| +0.2% | +$2.72K | ﹤0.01% | 2259 |
|
|
2015
Q2 | $1.16M | Buy |
144,410
+46,288
| +47% | +$373K | ﹤0.01% | 2653 |
|
|
2015
Q1 | $649K | Buy |
98,122
+1,923
| +2% | +$12.7K | ﹤0.01% | 2807 |
|
|
2014
Q4 | $613K | Buy |
96,199
+4,159
| +5% | +$26.5K | ﹤0.01% | 2884 |
|
|
2014
Q3 | $908K | Buy |
92,040
+983
| +1% | +$9.7K | ﹤0.01% | 2583 |
|
|
2014
Q2 | $1.03M | Sell |
91,057
-1,069
| -1% | -$12K | ﹤0.01% | 2574 |
|
|
2014
Q1 | $1.12M | Buy |
92,126
+646
| +0.7% | +$7.83K | ﹤0.01% | 2413 |
|
|
2013
Q4 | $1.15M | Sell |
91,480
-1,696
| -2% | -$21.4K | ﹤0.01% | 2395 |
|
|
2013
Q3 | $1.55M | Buy |
93,176
+5,421
| +6% | +$90.3K | ﹤0.01% | 2122 |
|
|
2013
Q2 | $1.33M | Buy |
+87,755
| New | +$1.33M | ﹤0.01% | 2164 |
|